The association between metabolic syndrome and the risk of prostate cancer high-grade prostate cancer advanced prostate cancer prostate cancer-specific mortality and biochemical recurrence

摘要

BackgroundAlthough a previous meta-analysis reported no association between metabolic syndrome (MetS) and prostate cancer risk, a number of studies suggest that MetS may be associated with the aggressiveness and progression of prostate cancer. However, these results have been inconsistent. This systematic review and meta-analysis investigated the nature of this association.